Movement disorders

Relieves muscle spasms and pain. Improves mobility and appetite. Aids in sleep.
Effects of Cannabidiol in Huntington's Disease
Abstract: Cannabidiol (CBD) is a major nonpsychoactive cannabinoid of marijuana. Based on reports indicating possible efficacy of CBD in dystonic movements (Neurology 1984; 34 [Suppl 1]: 147 and 1985; 35 [Suppl 1]: 201), we tried CBD in three patients with Huntington's disease (HD). The patients;, aged 30 to 56, had HD of 7 to 12 years' duration. Their condition has been slowly progressive and unresponsive to prior therapy with neuroleptics.... [...More]
Open Label Evaluation of Cannabidiol in Dystonic Movement Disorders
Cannabidiol (CBD) a nonpsychoactive cannabinoid of Cannabis, was given to 5 patients with dystonic movement disorders in a preliminary open pilot study. Oral doses of CBD rising from 100 t 600 mg/day over a 6 week period were administered along with standard medication. Dose-related improvement in dystonia was observed in all patients and ranged from 20 to 50%. Side-effects of CBD were mild and included hypotension, dry mouth, psychomotor slowing, lightheadedness, and sedation.... [...More]
Anticonvulsant Nature of Marihuana Smoking
Marihuana smoking, in conjunction with therapeutic doses of pheno-barbital and diphenylhydantoin, was apparently necessary for controlling seizures in one 24-year-old epileptic patient.... [...More]
Syndicate content